3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
167
Leukemia
86
Precursor Cell Lymphoblastic Leukemia-Lymphoma
71
Lymphoma
51
Myelodysplastic Syndromes
38
Congenital Abnormalities
32
Burkitt Lymphoma
29
Lymphoma, Non-Hodgkin
27
Recurrence
26
Leukemia, Myelomonocytic, Acute
26
Leukemia, Monocytic, Acute
26
Lymphoma, Mantle-Cell
23
Leukemia, Erythroblastic, Acute
23
Leukemia, Megakaryoblastic, Acute
21
Hodgkin Disease
18
Lymphoma, Large B-Cell, Diffuse
17
Lymphoma, Follicular
13
Myeloproliferative Disorders
12
Leukemia, Myelomonocytic, Chronic
11
Leukemia, Biphenotypic, Acute
11
Leukemia, Eosinophilic, Acute
9
Blast Crisis
9
Lymphoma, B-Cell
8
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
8
Anemia, Refractory, with Excess of Blasts
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Neoplasms
7
Multiple Myeloma
7
Leukemia, Basophilic, Acute
7
Leukemia, Lymphocytic, Chronic, B-Cell
6
Interventions
Temozolomide
7
Magnetic Resonance Spectroscopy
7
X-Rays
5
Phantoms, Imaging
5
Bevacizumab
5
Specimen Handling
4
Nuclear Medicine Department, Hospital
4
Carboplatin
3
Biopsy
3
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
Vemurafenib
2
Lapatinib
2
LY3023414
2
Everolimus
2
Etoposide
2
Erlotinib Hydrochloride
2
veliparib
1
pomalidomide
1
poly ICLC
1
picropodophyllin
1
marizomib
1
imetelstat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Ependymoma
×
Cytarabine
×
Clear all
No trials found.